How BMS Uses AI To Improve Study Design And Reduce Costs

In 2022, Bristol Myers Squibb (BMS) announced plans to work with AI developer Owkin to design and optimize cardiovascular drug trials. The...

Related Keywords

Ed Miseta ,Venkat Sethuraman ,Bristol Myers Squibb ,Bmsvenkat Sethuraman ,Data Sciences ,Chief Editor ,Global Biometrics ,Artificial Intelligence ,Digital Protocol Solution ,